Method and system for treatment of neurocardiogenic syncope
First Claim
Patent Images
1. A method for operating a cardiac stimulator, comprising:
- (a) monitoring a heart rate;
(b) detecting an indication of the onset of a syncopal episode, based on said monitoring;
(c) in response to said detecting, initiating delivery of one or more electro-stimulation pulses to a heart, timed to be delivered during a refractory period of the site to which they are applied, in a manner which at least partly alleviates or avoids syncope, wherein said delivery includes the delivery of nonexcitatory electric energy to the heart for the purpose of cardiac contractility modulation;
(d) repeating said detecting;
(e) repeating said initiating based on said repeated detection; and
(f) terminating delivery of said pulses after said detecting indicates no syncopal episode.
3 Assignments
0 Petitions
Accused Products
Abstract
A method and apparatus for treating or preventing neurocardiogenic syncope is disclosed. Upon detection of bradycardia or a drop in blood pressure indicating the onset of syncope, electrostimulation pulses are delivered during the heart'"'"'s refractory period. The pulses are non-excitatory but increase myocardial contractility and thereby increase cardiac output.
66 Citations
28 Claims
-
1. A method for operating a cardiac stimulator, comprising:
-
(a) monitoring a heart rate; (b) detecting an indication of the onset of a syncopal episode, based on said monitoring; (c) in response to said detecting, initiating delivery of one or more electro-stimulation pulses to a heart, timed to be delivered during a refractory period of the site to which they are applied, in a manner which at least partly alleviates or avoids syncope, wherein said delivery includes the delivery of nonexcitatory electric energy to the heart for the purpose of cardiac contractility modulation; (d) repeating said detecting; (e) repeating said initiating based on said repeated detection; and (f) terminating delivery of said pulses after said detecting indicates no syncopal episode. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 25, 26, 27)
-
-
14. A cardiac stimulator comprising:
-
(a) one or more sensing channels configured to monitor a heart rate and to detect an indication of the onset of a syncopal episode, based on the monitoring; (b) a stimulation channel adapted to deliver one or more electro-stimulation pulses suitable to increase cardiac contractility when delivered during a refractory period of cardiac tissue to which they are delivered; and (c) a controller configured to (i) determine one or both of bradycardia and syncope based on input from said sensing channel; (ii) initiate delivery of said one or more pulses on said channel, based on said determination, at a timing which is during a refractory period for sites to which pulses are delivered, wherein said delivery includes the delivery of non-excitatory electric energy to the heart for the purpose of cardiac contractility modulation; and (iii) terminate delivery of said one or more pulses based on a determination of no bradycardia or no syncope. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 28)
-
Specification